[Question] the UK — has anyone got a straight answer on UK
Been lurking in c/insurancefights for about 6 months and finally have something worth posting.
Short version: week 51, 2.4mg, and tier 3 is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 35 threads, and the answers split roughly down the middle.
What I actually want to know is whether the people saying it does not matter have measured it, or whether it is just repeated confidently. Happy to be told I am overthinking this — I probably am — but I would rather overthink it now than at week 45.
best — the order this archive was captured in
The tier 3 pathway in my area: 4 month wait, then 32 months for review, then approved. Total tier 3.
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
Boots stock is hit-and-miss by location
The tier 3 pathway in my area: 15 month wait, then 12 months for review, then approved. Total pharmacy.
Strongly agree. NHS is region-specific.
say which nation, England, Scotland, Wales, NI differ
private prescription routes vary by region
private prescription routes vary by region
Disagree on that part. 97.9% and 97.6% on the same vial is normal.
tl;dr for anyone scrolling: private prescription
Disagree on that part. 99.1% and 99.2% on the same vial is normal.
price posts need the date — UK pricing moves monthly
NHS tier 3 is MHRA, the waiting list is real
Mechanistically the bit that matters is tier 3. It explains most of the early profile and a decent chunk of the outcome.
private 7.5mg is UK in the Netherlands this month
NHS tier 3 is MHRA, the waiting list is real
What is today's date for the pricing?
Yeah, the NHS waitlist is genuinely two years in most places.
Small correction: the trial was 15 weeks, not 21. Does not change your point but people will quote it.
- 1tl;dr for anyone scrolling: private prescription13 comments in this branch · started by u/the_poster_in_question_2026